30233072|t|Hyperoside protects the blood-brain barrier from neurotoxicity of amyloid beta 1-42.
30233072|a|Mounting evidence indicates that amyloid beta protein (Abeta) exerts neurotoxicity by disrupting the blood-brain barrier (BBB) in Alzheimer's disease. Hyperoside has neuroprotective effects both in vitro and in vivo against Abeta. Our previous study found that hyperoside suppressed Abeta1-42-induced leakage of the BBB, however, the mechanism remains unclear. In this study, bEnd.3 cells were pretreated with 50, 200, or 500 microM hyperoside for 2 hours, and then exposed to Abeta1-42 for 24 hours. Cell viability was determined using 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide assay. Flow cytometry and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay were used to analyze cell apoptosis. Western blot assay was carried out to analyze expression levels of Bax, Bcl-2, cytochrome c, caspase-3, caspse-8, caspase-9, caspase-12, occludin, claudin-5, zonula occludens-1, matrix metalloproteinase-2 (MMP-2), and MMP-9. Exposure to Abeta1-42 alone remarkably induced bEnd.3 cell apoptosis; increased ratios of cleaved caspase-9/caspase-9, Bax/Bcl-2, cleaved caspase-8/caspase-8, and cleaved caspase-12/caspase-12; increased expression of cytochrome c and activity of caspase-3; diminished levels of zonula occludens-1, claudin-5, and occludin; and increased levels of MMP-2 and MMP-9. However, hyperoside pretreatment reversed these changes in a dose-dependent manner. Our findings confirm that hyperoside alleviates fibrillar Abeta1-42-induced BBB disruption, thus offering a feasible therapeutic application in Alzheimer's disease.
30233072	0	10	Hyperoside	Chemical	MESH:C021304
30233072	49	62	neurotoxicity	Disease	MESH:D020258
30233072	140	145	Abeta	Gene	11820
30233072	154	167	neurotoxicity	Disease	MESH:D020258
30233072	215	234	Alzheimer's disease	Disease	MESH:D000544
30233072	236	246	Hyperoside	Chemical	MESH:C021304
30233072	309	314	Abeta	Gene	11820
30233072	346	356	hyperoside	Chemical	MESH:C021304
30233072	461	467	bEnd.3	CellLine	CVCL:0170
30233072	518	528	hyperoside	Chemical	MESH:C021304
30233072	622	687	3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide	Chemical	MESH:C000598529
30233072	714	751	terminal deoxynucleotidyl transferase	Gene	21673
30233072	761	765	dUTP	Chemical	MESH:C027078
30233072	894	897	Bax	Gene	12028
30233072	899	904	Bcl-2	Gene	12043
30233072	920	929	caspase-3	Gene	12367
30233072	941	950	caspase-9	Gene	12371
30233072	952	962	caspase-12	Gene	12364
30233072	964	972	occludin	Gene	18260
30233072	974	983	claudin-5	Gene	12741
30233072	1005	1031	matrix metalloproteinase-2	Gene	17390
30233072	1033	1038	MMP-2	Gene	17390
30233072	1045	1050	MMP-9	Gene	17395
30233072	1099	1105	bEnd.3	CellLine	CVCL:0170
30233072	1150	1159	caspase-9	Gene	12371
30233072	1160	1169	caspase-9	Gene	12371
30233072	1171	1174	Bax	Gene	12028
30233072	1175	1180	Bcl-2	Gene	12043
30233072	1190	1199	caspase-8	Gene	12370
30233072	1200	1209	caspase-8	Gene	12370
30233072	1223	1233	caspase-12	Gene	12364
30233072	1234	1244	caspase-12	Gene	12364
30233072	1299	1308	caspase-3	Gene	12367
30233072	1351	1360	claudin-5	Gene	12741
30233072	1366	1374	occludin	Gene	18260
30233072	1400	1405	MMP-2	Gene	17390
30233072	1410	1415	MMP-9	Gene	17395
30233072	1426	1436	hyperoside	Chemical	MESH:C021304
30233072	1527	1537	hyperoside	Chemical	MESH:C021304
30233072	1645	1664	Alzheimer's disease	Disease	MESH:D000544
30233072	Negative_Correlation	MESH:C021304	MESH:D020258
30233072	Positive_Correlation	MESH:C021304	12741
30233072	Association	MESH:C021304	17395
30233072	Association	MESH:C021304	17390
30233072	Positive_Correlation	MESH:C021304	18260
30233072	Association	MESH:C027078	21673
30233072	Negative_Correlation	MESH:C021304	MESH:D000544
30233072	Negative_Correlation	MESH:C021304	11820
30233072	Association	MESH:D000544	11820

